First Citizens Bank & Trust’s Ligand Pharmaceuticals LGND Stock Holding History

First Citizens Bank & Trust’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,501	Closed	-$231K	–	464
2017 Q1	$231K	Sell	3,501 -189	-5%	-$12.4K	0.03%	430
2016 Q4	$234K	Sell	3,690 -1,661	-31%	-$105K	0.03%	412
2016 Q3	$341K	Sell	5,351 -1,816	-25%	-$133K	0.03%	368
2016 Q2	$533K	Sell	7,167 -6,103	-46%	-$453K	0.05%	259
2016 Q1	$886K	Sell	13,270 -9,812	-43%	-$596K	0.07%	164
2015 Q4	$1.56M	Sell	23,082 -24,894	-52%	-$1.54M	0.11%	130
2015 Q3	$2.56M	Buy	+47,976	New	+$2.91M	0.19%	107

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

First Citizens Bank & Trust's LGND Position: Q2 2017 in Review

First Citizens Bank & Trust sold out of Ligand Pharmaceuticals (LGND) in Q2 2017, closing a stake of 3,501 shares — an estimated $231K sold.

First Citizens Bank & Trust first reported a position in LGND in Q3 2015 and held it in 7 quarters. The position peaked at $2.56M in Q3 2015. 265 funds tracked by Wall St. Rank hold LGND as of Q2 2017.

First Citizens Bank & Trust reported no remaining Ligand Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
First Citizens Bank & Trust sold 3,501 Ligand Pharmaceuticals shares in Q2 2017, an estimated $231K.
First Citizens Bank & Trust first reported a position in Ligand Pharmaceuticals in Q3 2015 and held it in 7 quarters.
First Citizens Bank & Trust's Ligand Pharmaceuticals position peaked at $2.56M in Q3 2015.
265 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2017.

Based on First Citizens Bank & Trust's 13F filing for Q2 2017, filed 24 Jul 2017.